Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents.
Polimeni A, Sorrentino S, Spaccarotella C, Mongiardo A, Sabatino J, De Rosa S, Gori T, Indolfi C.
Interv Cardiol Clin. 2022 Oct;11(4):465-473. doi: 10.1016/j.iccl.2022.07.002.
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents.
Polimeni A, Sorrentino S, Spaccarotella C, Mongiardo A, Sabatino J, De Rosa S, Gori T, Indolfi C.
Cardiol Clin. 2020 Nov;38(4):639-647. doi: 10.1016/j.ccl.2020.07.008. Epub 2020 Sep 17.
In-Stent Restenosis.
Kawai K, Virmani R, Finn AV.
Interv Cardiol Clin. 2022 Oct;11(4):429-443. doi: 10.1016/j.iccl.2022.02.005. Epub 2022 Sep 24.
Italian Multicenter Registry of Bare Metal Stent Use in Modern Percutaneous Coronary Intervention Era (AMARCORD): A multicenter observational study.
Giannini F, Pagnesi M, Campo G, Donahue M, Ferri LA, Briguori C, Stefanini GG, Scardala R, Sardella G, De Rosa S, Figini F, Monello A, Pastormerlo LE, Testa L, Nicolino A, Ielasi A, Durante A, Leone A, Tzanis G, Mangieri A, Ciccarelli G, Briani M, Reimers B, Ceccacci A, Indolfi C, Sheiban I, Palmieri C, Bedogni F, Tespili M, Latib A, Gallo F, Colombo A.
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):411-420. doi: 10.1002/ccd.28798. Epub 2020 Mar 21.
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
Giacoppo D, Alfonso F, Xu B, Claessen BEPM, Adriaenssens T, Jensen C, Pérez-Vizcayno MJ, Kang DY, Degenhardt R, Pleva L, Baan J, Cuesta J, Park DW, Kukla P, Jiménez-Quevedo P, Unverdorben M, Gao R, Naber CK, Park SJ, Henriques JPS, Kastrati A, Byrne RA.
J Am Coll Cardiol. 2020 Jun 2;75(21):2664-2678. doi: 10.1016/j.jacc.2020.04.006.
Does intravascular ultrasound provide clinical benefits for percutaneous coronary intervention with bare-metal stent implantation? A meta-analysis of randomized controlled trials.
Lodi-Junqueira L, de Sousa MR, da Paixão LC, Kelles SM, Amaral CF, Ribeiro AL.
Syst Rev. 2012 Sep 21;1:42. doi: 10.1186/2046-4053-1-42.
Randomized comparison between bare-metal stent plus colchicine versus drug-eluting stent alone in prevention of clinical adverse events after percutaneous coronary intervention.
Correa-Sadouet C, Rodríguez-Granillo AM, Gallardo C, Mieres J, Fontana L, Curotto MV, Wainer P, Allende NG, Fernández-Pereira C, M Vetulli H, la Hoz RP, Kastrati A, Rodríguez AE; ORCA investigators.
Future Cardiol. 2021 Jul;17(4):539-547. doi: 10.2217/fca-2020-0161. Epub 2020 Nov 11.
The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S, Effat M, Rahman S, Abdallah M, Leesar M.
Cardiovasc Ther. 2015 Dec;33(6):360-6. doi: 10.1111/1755-5922.12160.
Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
Yoshimura M, Umemoto S, Kawano R, Hiromoto M, Yamada M, Fujimura T, Tanaka M, Nao T, Miura T, Yano M.
Int Heart J. 2021;62(5):970-979. doi: 10.1536/ihj.21-015.
Spectral analysis related to bare-metal and drug-eluting coronary stent implantation.
Silva RM, Silva CA, Greco OJ, Moreira Mda C.
Arq Bras Cardiol. 2014 Aug;103(2):138-45. doi: 10.5935/abc.20140094. Epub 2014 Jul 15.
